MAGEA6 Polyclonal Antibody

MAGEA6 Polyclonal Antibody

The MAGEA6 polyclonal antibody is a highly specific and sensitive tool designed for the detection and analysis of MAGEA6 protein expression in various biological samples. MAGEA6, a member of the melanoma-associated antigen (MAGE) family, is known to be overexpressed in a wide range of cancer types, including melanoma, lung, breast, and ovarian cancers. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to a specific region of the MAGEA6 protein, ensuring its high affinity and specificity.

This polyclonal antibody offers exceptional performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been rigorously validated to provide reliable and reproducible results, making it an ideal choice for both research and diagnostic purposes. With its ability to specifically recognize MAGEA6, this antibody enables researchers to investigate the role of MAGEA6 in cancer development, progression, and potential therapeutic targets.

The MAGEA6 polyclonal antibody is supplied as a liquid formulation, ready to use for immediate experimentation. It has been optimized for use in a variety of sample types, including cell lysates, tissue sections, and cultured cells. Its high sensitivity allows for the detection of low levels of MAGEA6 protein, ensuring accurate and precise quantification. Additionally, this antibody exhibits minimal cross-reactivity with other MAGE family members, further enhancing its specificity and reliability.

In summary, the MAGEA6 polyclonal antibody is a valuable tool for researchers and clinicians interested in studying the expression and function of MAGEA6 in cancer. Its high specificity, sensitivity, and versatility make it an essential component of any study aiming to elucidate the role of MAGEA6 in cancer biology.